Subscribe to Newsletter

Clinical

Business & Education Business

Business in Brief

| Markella Loi

A roundup of this month’s business news – gene and cell therapy advancement, business partnerships and space investigation

Techniques & Tools Gas Chromatography

What’s New in Chromatography?

| Markella Loi | 3 min read

Whether you’re creating a new perfume or want to test ocean water for nuclear contaminants, chromatography has the answers

Business & Education Professional Development

The Greatest Analytical Odyssey: Part 1

| Markella Loi | 6 min read

We ask our 2023 Power Listers what the biggest challenge facing the field is right now…

Fields & Applications Clinical

Mushroom for Improvement

| Jessica Allerton | 4 min read

How analytical testing of psychedelic mushrooms can help unveil their true therapeutic potential

Techniques & Tools Mass Spectrometry

What’s New in Mass Spec?

| Markella Loi | 3 min read

The latest mass spec news: analyzing asteroids, creating sustainable materials from worm slime, and advancing cellular therapies

Business & Education Professional Development

Scientist, Engineer, Inventor

| Jessica Allerton, James Strachan | 6 min read

Sitting Down With… Frances S. Ligler, Eppright Chair and Professor of Biomedical Engineering, Texas A&M University, USA

Techniques & Tools Spectroscopy

Enter the METRIX

| Markella Loi | 5 min read

We plug into the (RAMAN)METRIX with Juergen Popp, who discusses clinical spectroscopy’s exciting AI-enabled future

Fields & Applications Clinical

Milk Monitor

| Markella Loi | 4 min read

How DNA sequencing of breast milk can replace tissue imaging for early diagnosis of breast cancer in pregnant and lactating women

Techniques & Tools Mass Spectrometry

What’s New in Mass Spec?

| Markella Loi | 3 min read

Mass spec returns in the clinic with the latest studies on ectopic pregnancy, Parkinson’s Disease, ketamine exposure, and chronic kidney disease

Techniques & Tools Spectroscopy

A Molecular U-Turn

| Jessica Allerton

Structural insights of amyloid β bound to glycolipids on the surface of nerve cells could lead to new treatments for Alzheimer’s disease

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register